Long-term outcome in neuroZika: When biological diagnosis matters.
Annie LannuzelJean-Louis FergéQuentin LobjoisAissatou SignateBenoit RozéBenoit TressièresYoann MadecPascale PoullainCécile HerrmannFatiha NajioullahEavan McGovernAnne-Charlotte SavidanRuddy ValentinoSébastien BreurecRaymond CésaireEtienne HirschPierre-Marie LledoGuillaume ThieryAndré CabiéFrançoise LazariniEmmanuel RozePublished in: Neurology (2019)
NeuroZika spectrum represents a heterogeneous group of clinical neurologic manifestations. During an outbreak, clinicians should consider neuroZika in patients presenting with cranial nerve palsies and a mixed neurologic disorder. Long-term sequelae are frequent in NeuroZika. ZIKV reverse-transcription PCR status at admission can inform prognosis and should therefore be taken into consideration in the management of hospitalized patients.